Merck posts quarterly loss due to Cidara charge, sales rise 5%

0
146
Merck & Co on Thursday reported a loss for the first quarter as an acquisition-related charge offset a 5% increase ​in product sales driven by cancer and respiratory drugs.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here